157 related articles for article (PubMed ID: 29155024)
1. Linearization improves the repeatability of quantitative dynamic contrast-enhanced MRI.
Jones KM; Pagel MD; Cárdenas-Rodríguez J
Magn Reson Imaging; 2018 Apr; 47():16-24. PubMed ID: 29155024
[TBL] [Abstract][Full Text] [Related]
2. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
Li Y; Liu G; Lou X; Chen Z; Ma L
Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
4. Dependence of DCE-MRI biomarker values on analysis algorithm.
Ng CS; Wei W; Bankson JA; Ravoori MK; Han L; Brammer DW; Klumpp S; Waterton JC; Jackson EF
PLoS One; 2015; 10(7):e0130168. PubMed ID: 26208254
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of neovascularization patterns in an orthotopic rat glioma model with dynamic contrast-enhanced MRI.
Xuesong D; Wei X; Heng L; Xiao C; Shunan W; Yu G; Weiguo Z
Acta Radiol; 2017 Sep; 58(9):1138-1146. PubMed ID: 27956462
[TBL] [Abstract][Full Text] [Related]
6. Accelerated Brain DCE-MRI Using Iterative Reconstruction With Total Generalized Variation Penalty for Quantitative Pharmacokinetic Analysis: A Feasibility Study.
Wang C; Yin FF; Kirkpatrick JP; Chang Z
Technol Cancer Res Treat; 2017 Aug; 16(4):446-460. PubMed ID: 27215931
[TBL] [Abstract][Full Text] [Related]
7. Improved repeatability of dynamic contrast-enhanced MRI using the complex MRI signal to derive arterial input functions: a test-retest study in prostate cancer patients.
Klawer EME; van Houdt PJ; Simonis FFJ; van den Berg CAT; Pos FJ; Heijmink SWTPJ; Isebaert S; Haustermans K; van der Heide UA
Magn Reson Med; 2019 May; 81(5):3358-3369. PubMed ID: 30656738
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of dynamic contrast-enhanced MRI biomarkers for stratified cancer medicine: How do permeability and perfusion vary between human tumours?
Little RA; Barjat H; Hare JI; Jenner M; Watson Y; Cheung S; Holliday K; Zhang W; O'Connor JPB; Barry ST; Puri S; Parker GJM; Waterton JC
Magn Reson Imaging; 2018 Feb; 46():98-105. PubMed ID: 29154898
[TBL] [Abstract][Full Text] [Related]
9. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
Murayama K; Nishiyama Y; Hirose Y; Abe M; Ohyu S; Ninomiya A; Fukuba T; Katada K; Toyama H
Magn Reson Med Sci; 2018 Jan; 17(1):42-49. PubMed ID: 28515410
[TBL] [Abstract][Full Text] [Related]
10. Pseudo Test-Retest Evaluation of Millimeter-Resolution Whole-Brain Dynamic Contrast-enhanced MRI in Patients with High-Grade Glioma.
Bliesener Y; Lebel RM; Acharya J; Frayne R; Nayak KS
Radiology; 2021 Aug; 300(2):410-420. PubMed ID: 34100683
[TBL] [Abstract][Full Text] [Related]
11. T1 in high-grade glioma and the influence of different measurement strategies on parameter estimations in DCE-MRI.
Larsson C; Kleppestø M; Grothe I; Vardal J; Bjørnerud A
J Magn Reson Imaging; 2015 Jul; 42(1):97-104. PubMed ID: 25350816
[TBL] [Abstract][Full Text] [Related]
12. Heuristic linear mapping of physiological parameters in dynamic contrast-enhanced MRI without T₁ measurement and contrast agent concentration.
Yuan J; Chow SK; King AD; Yeung DK
J Magn Reson Imaging; 2012 Apr; 35(4):916-25. PubMed ID: 22095582
[TBL] [Abstract][Full Text] [Related]
13. Signal intensity form of the Tofts model for quantitative analysis of prostate dynamic contrast enhanced MRI data.
Fan X; Chatterjee A; Medved M; Oto A; Karczmar GS
Phys Med Biol; 2021 Jan; 66(2):025002. PubMed ID: 33181487
[TBL] [Abstract][Full Text] [Related]
14. Improved correlation to quantitative DCE-MRI pharmacokinetic parameters using a modified initial area under the uptake curve (mIAUC) approach.
Cheng HL
J Magn Reson Imaging; 2009 Oct; 30(4):864-72. PubMed ID: 19787732
[TBL] [Abstract][Full Text] [Related]
15. In Vivo DCE-MRI for the Discrimination Between Glioblastoma and Radiation Necrosis in Rats.
Bolcaen J; Descamps B; Acou M; Deblaere K; den Broecke CV; Boterberg T; Vanhove C; Goethals I
Mol Imaging Biol; 2017 Dec; 19(6):857-866. PubMed ID: 28303489
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis.
Galbraith SM; Lodge MA; Taylor NJ; Rustin GJ; Bentzen S; Stirling JJ; Padhani AR
NMR Biomed; 2002 Apr; 15(2):132-42. PubMed ID: 11870909
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software.
Conte GM; Castellano A; Altabella L; Iadanza A; Cadioli M; Falini A; Anzalone N
Radiol Med; 2017 Apr; 122(4):294-302. PubMed ID: 28070841
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Tumor Hypoxia in C6 Glioma Rat Model With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Hou W; Xue Y; Tang W; Pan H; Xu M; Li X; Bi S; Shen Y; Qian Y; Yu Y
Acad Radiol; 2019 Aug; 26(8):e224-e232. PubMed ID: 30385206
[TBL] [Abstract][Full Text] [Related]
19. Effects of arterial input function selection on kinetic parameters in brain dynamic contrast-enhanced MRI.
Keil VC; Mädler B; Gieseke J; Fimmers R; Hattingen E; Schild HH; Hadizadeh DR
Magn Reson Imaging; 2017 Jul; 40():83-90. PubMed ID: 28438713
[TBL] [Abstract][Full Text] [Related]
20. Selection of Fitting Model and Arterial Input Function for Repeatability in Dynamic Contrast-Enhanced Prostate MRI.
Peled S; Vangel M; Kikinis R; Tempany CM; Fennessy FM; Fedorov A
Acad Radiol; 2019 Sep; 26(9):e241-e251. PubMed ID: 30467073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
